Calcium Chloride IV Solution Recalled Due to Sterility Assurance Concerns
Pine Pharmaceuticals recalls Calcium Chloride IV Solution for Intravenous Injection, 20 mg/mL (lot 70101), due to lack of assurance of sterility. Approximately 130 units were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves lack of assurance of sterility in an intravenous medication, representing a risk-of-harm product. No illnesses or injuries have been reported in the source text, limiting the score to 3 per the rubric criteria.
Plain-English summary
Pine Pharmaceuticals, LLC is recalling Calcium Chloride Solution for Intravenous Injection, 20 mg/mL supplied in 500 mL bags (Rx only). The affected lot is number 70101 with an expiration date of 1/17/2024. Approximately 130 units were distributed nationwide within the United States.
The product is being recalled due to lack of assurance of sterility. The FDA classified this as a Class II recall.
Patients and healthcare facilities that received this lot should not use the product and should contact Pine Pharmaceuticals, LLC or their healthcare provider for further information.
The recalled product
- Product
- Calcium chloride Solution for Intravenous Injection, 20 mg/mL, 500 mL bags, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
- Manufacturer
- Pine Pharmaceuticals, LLC
- Category
- Drug
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 70101
- Exp. Date 1/17/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27